VEGF Human ELISA Kit Market: Global Market Growth, Trends, and Forecast
The VEGF Human ELISA Kit Market is witnessing steady growth as researchers and healthcare professionals increasingly require accurate methods for measuring vascular endothelial growth factor (VEGF) levels in biological samples. VEGF is an important protein associated with angiogenesis and is studied extensively in cancer, cardiovascular conditions, inflammation, and other disease-related research.
The market is supported by the rising prevalence of chronic diseases and increasing demand for early disease detection and monitoring. ELISA kits provide researchers with practical tools for quantifying VEGF in samples such as serum, plasma, and whole blood. Sandwich ELISA is an important detection approach because of its sensitivity and specificity.
Technological advancements are improving the sensitivity, accuracy, automation, and efficiency of ELISA testing. Increasing research and development activities in angiogenesis, immunology, oncology, and regenerative medicine are also creating additional opportunities.
According to the referenced market report, the market was estimated at USD 1.65 billion in 2023 and is projected to reach USD 2.8 billion by 2032, representing a CAGR of approximately 6.08% during the forecast period.